 | • レポートコード：MRC308GR11486 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の非オピオイド鎮痛薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の非オピオイド鎮痛薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 非オピオイド鎮痛薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
非オピオイド鎮痛薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・ジクロフェナクナトリウム、アセトアミノフェン、インドメタシン、イブプロフェン、アスピリン、その他
用途別セグメント
・軽度痛み、中程度痛み
主要な市場プレーヤー
・WEX Pharmaceuticals Inc.、BASF、Xinhua Pharm、Johnson & Johnson（McNeil Consumer Healthcare）、Granules Biocause、Novacyl、Pfizer、Hisoar、Anant Pharmaceuticals Pvt. Ltd.、Strides Shasun、SI Group、Elam Pharma、AdvaCare Pharma、IOL、Jingye Group、NS Chemicals、Hunan Zhongnan Pharmaceutical、Nanjing Pharmaceutical Factory、Huayin Jinqiancheng Pharmaceutical Co., Ltd.、Mallinckrodt Pharmaceuticals
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、非オピオイド鎮痛薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な非オピオイド鎮痛薬メーカーの企業概要、2019年～2022年までの非オピオイド鎮痛薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な非オピオイド鎮痛薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別非オピオイド鎮痛薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの非オピオイド鎮痛薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での非オピオイド鎮痛薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および非オピオイド鎮痛薬の産業チェーンを掲載しています。
・第14、15章では、非オピオイド鎮痛薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 非オピオイド鎮痛薬の概要
– 種類別分析（2018年vs2022年vs2029年）：ジクロフェナクナトリウム、アセトアミノフェン、インドメタシン、イブプロフェン、アスピリン、その他
– 用途別分析（2018年vs2022年vs2029年）：軽度痛み、中程度痛み
– 世界の非オピオイド鎮痛薬市場規模・予測
– 世界の非オピオイド鎮痛薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– WEX Pharmaceuticals Inc.、BASF、Xinhua Pharm、Johnson & Johnson（McNeil Consumer Healthcare）、Granules Biocause、Novacyl、Pfizer、Hisoar、Anant Pharmaceuticals Pvt. Ltd.、Strides Shasun、SI Group、Elam Pharma、AdvaCare Pharma、IOL、Jingye Group、NS Chemicals、Hunan Zhongnan Pharmaceutical、Nanjing Pharmaceutical Factory、Huayin Jinqiancheng Pharmaceutical Co., Ltd.、Mallinckrodt Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ジクロフェナクナトリウム、アセトアミノフェン、インドメタシン、イブプロフェン、アスピリン、その他
・用途別分析2018年-2029年：軽度痛み、中程度痛み
・非オピオイド鎮痛薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・非オピオイド鎮痛薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・非オピオイド鎮痛薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・非オピオイド鎮痛薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・非オピオイド鎮痛薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Non-opioid Pain Med
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-opioid Pain Med Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Diclofenac Sodium
1.3.3 Acetaminophen
1.3.4 Indomethacin
1.3.5 Ibuprofen
1.3.6 Aspirin
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-opioid Pain Med Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Mild Pain
1.4.3 Moderate Pain
1.5 Global Non-opioid Pain Med Market Size & Forecast
1.5.1 Global Non-opioid Pain Med Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-opioid Pain Med Sales Quantity (2018-2029)
1.5.3 Global Non-opioid Pain Med Average Price (2018-2029)
2 Manufacturers Profiles
2.1 WEX Pharmaceuticals Inc.
2.1.1 WEX Pharmaceuticals Inc. Details
2.1.2 WEX Pharmaceuticals Inc. Major Business
2.1.3 WEX Pharmaceuticals Inc. Non-opioid Pain Med Product and Services
2.1.4 WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 WEX Pharmaceuticals Inc. Recent Developments/Updates
2.2 BASF
2.2.1 BASF Details
2.2.2 BASF Major Business
2.2.3 BASF Non-opioid Pain Med Product and Services
2.2.4 BASF Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BASF Recent Developments/Updates
2.3 Xinhua Pharm
2.3.1 Xinhua Pharm Details
2.3.2 Xinhua Pharm Major Business
2.3.3 Xinhua Pharm Non-opioid Pain Med Product and Services
2.3.4 Xinhua Pharm Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Xinhua Pharm Recent Developments/Updates
2.4 Johnson & Johnson（McNeil Consumer Healthcare）
2.4.1 Johnson & Johnson（McNeil Consumer Healthcare） Details
2.4.2 Johnson & Johnson（McNeil Consumer Healthcare） Major Business
2.4.3 Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Product and Services
2.4.4 Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Johnson & Johnson（McNeil Consumer Healthcare） Recent Developments/Updates
2.5 Granules Biocause
2.5.1 Granules Biocause Details
2.5.2 Granules Biocause Major Business
2.5.3 Granules Biocause Non-opioid Pain Med Product and Services
2.5.4 Granules Biocause Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Granules Biocause Recent Developments/Updates
2.6 Novacyl
2.6.1 Novacyl Details
2.6.2 Novacyl Major Business
2.6.3 Novacyl Non-opioid Pain Med Product and Services
2.6.4 Novacyl Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novacyl Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Non-opioid Pain Med Product and Services
2.7.4 Pfizer Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Hisoar
2.8.1 Hisoar Details
2.8.2 Hisoar Major Business
2.8.3 Hisoar Non-opioid Pain Med Product and Services
2.8.4 Hisoar Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hisoar Recent Developments/Updates
2.9 Anant Pharmaceuticals Pvt. Ltd.
2.9.1 Anant Pharmaceuticals Pvt. Ltd. Details
2.9.2 Anant Pharmaceuticals Pvt. Ltd. Major Business
2.9.3 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product and Services
2.9.4 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Anant Pharmaceuticals Pvt. Ltd. Recent Developments/Updates
2.10 Strides Shasun
2.10.1 Strides Shasun Details
2.10.2 Strides Shasun Major Business
2.10.3 Strides Shasun Non-opioid Pain Med Product and Services
2.10.4 Strides Shasun Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Strides Shasun Recent Developments/Updates
2.11 SI Group
2.11.1 SI Group Details
2.11.2 SI Group Major Business
2.11.3 SI Group Non-opioid Pain Med Product and Services
2.11.4 SI Group Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 SI Group Recent Developments/Updates
2.12 Elam Pharma
2.12.1 Elam Pharma Details
2.12.2 Elam Pharma Major Business
2.12.3 Elam Pharma Non-opioid Pain Med Product and Services
2.12.4 Elam Pharma Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Elam Pharma Recent Developments/Updates
2.13 AdvaCare Pharma
2.13.1 AdvaCare Pharma Details
2.13.2 AdvaCare Pharma Major Business
2.13.3 AdvaCare Pharma Non-opioid Pain Med Product and Services
2.13.4 AdvaCare Pharma Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 AdvaCare Pharma Recent Developments/Updates
2.14 IOL
2.14.1 IOL Details
2.14.2 IOL Major Business
2.14.3 IOL Non-opioid Pain Med Product and Services
2.14.4 IOL Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 IOL Recent Developments/Updates
2.15 Jingye Group
2.15.1 Jingye Group Details
2.15.2 Jingye Group Major Business
2.15.3 Jingye Group Non-opioid Pain Med Product and Services
2.15.4 Jingye Group Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Jingye Group Recent Developments/Updates
2.16 NS Chemicals
2.16.1 NS Chemicals Details
2.16.2 NS Chemicals Major Business
2.16.3 NS Chemicals Non-opioid Pain Med Product and Services
2.16.4 NS Chemicals Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 NS Chemicals Recent Developments/Updates
2.17 Hunan Zhongnan Pharmaceutical
2.17.1 Hunan Zhongnan Pharmaceutical Details
2.17.2 Hunan Zhongnan Pharmaceutical Major Business
2.17.3 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product and Services
2.17.4 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Hunan Zhongnan Pharmaceutical Recent Developments/Updates
2.18 Nanjing Pharmaceutical Factory
2.18.1 Nanjing Pharmaceutical Factory Details
2.18.2 Nanjing Pharmaceutical Factory Major Business
2.18.3 Nanjing Pharmaceutical Factory Non-opioid Pain Med Product and Services
2.18.4 Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
2.19 Huayin Jinqiancheng Pharmaceutical Co., Ltd.
2.19.1 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Details
2.19.2 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Major Business
2.19.3 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product and Services
2.19.4 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Recent Developments/Updates
2.20 Mallinckrodt Pharmaceuticals
2.20.1 Mallinckrodt Pharmaceuticals Details
2.20.2 Mallinckrodt Pharmaceuticals Major Business
2.20.3 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product and Services
2.20.4 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Non-opioid Pain Med by Manufacturer
3.1 Global Non-opioid Pain Med Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-opioid Pain Med Revenue by Manufacturer (2018-2023)
3.3 Global Non-opioid Pain Med Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-opioid Pain Med by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-opioid Pain Med Manufacturer Market Share in 2022
3.4.2 Top 6 Non-opioid Pain Med Manufacturer Market Share in 2022
3.5 Non-opioid Pain Med Market: Overall Company Footprint Analysis
3.5.1 Non-opioid Pain Med Market: Region Footprint
3.5.2 Non-opioid Pain Med Market: Company Product Type Footprint
3.5.3 Non-opioid Pain Med Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Non-opioid Pain Med Market Size by Region
4.1.1 Global Non-opioid Pain Med Sales Quantity by Region (2018-2029)
4.1.2 Global Non-opioid Pain Med Consumption Value by Region (2018-2029)
4.1.3 Global Non-opioid Pain Med Average Price by Region (2018-2029)
4.2 North America Non-opioid Pain Med Consumption Value (2018-2029)
4.3 Europe Non-opioid Pain Med Consumption Value (2018-2029)
4.4 Asia-Pacific Non-opioid Pain Med Consumption Value (2018-2029)
4.5 South America Non-opioid Pain Med Consumption Value (2018-2029)
4.6 Middle East and Africa Non-opioid Pain Med Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Non-opioid Pain Med Sales Quantity by Type (2018-2029)
5.2 Global Non-opioid Pain Med Consumption Value by Type (2018-2029)
5.3 Global Non-opioid Pain Med Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Non-opioid Pain Med Sales Quantity by Application (2018-2029)
6.2 Global Non-opioid Pain Med Consumption Value by Application (2018-2029)
6.3 Global Non-opioid Pain Med Average Price by Application (2018-2029)
7 North America
7.1 North America Non-opioid Pain Med Sales Quantity by Type (2018-2029)
7.2 North America Non-opioid Pain Med Sales Quantity by Application (2018-2029)
7.3 North America Non-opioid Pain Med Market Size by Country
7.3.1 North America Non-opioid Pain Med Sales Quantity by Country (2018-2029)
7.3.2 North America Non-opioid Pain Med Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Non-opioid Pain Med Sales Quantity by Type (2018-2029)
8.2 Europe Non-opioid Pain Med Sales Quantity by Application (2018-2029)
8.3 Europe Non-opioid Pain Med Market Size by Country
8.3.1 Europe Non-opioid Pain Med Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-opioid Pain Med Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Non-opioid Pain Med Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-opioid Pain Med Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-opioid Pain Med Market Size by Region
9.3.1 Asia-Pacific Non-opioid Pain Med Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-opioid Pain Med Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Non-opioid Pain Med Sales Quantity by Type (2018-2029)
10.2 South America Non-opioid Pain Med Sales Quantity by Application (2018-2029)
10.3 South America Non-opioid Pain Med Market Size by Country
10.3.1 South America Non-opioid Pain Med Sales Quantity by Country (2018-2029)
10.3.2 South America Non-opioid Pain Med Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Non-opioid Pain Med Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-opioid Pain Med Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-opioid Pain Med Market Size by Country
11.3.1 Middle East & Africa Non-opioid Pain Med Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-opioid Pain Med Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Non-opioid Pain Med Market Drivers
12.2 Non-opioid Pain Med Market Restraints
12.3 Non-opioid Pain Med Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Non-opioid Pain Med and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-opioid Pain Med
13.3 Non-opioid Pain Med Production Process
13.4 Non-opioid Pain Med Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-opioid Pain Med Typical Distributors
14.3 Non-opioid Pain Med Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Non-opioid Pain Med Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-opioid Pain Med Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. WEX Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 4. WEX Pharmaceuticals Inc. Major Business
Table 5. WEX Pharmaceuticals Inc. Non-opioid Pain Med Product and Services
Table 6. WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. WEX Pharmaceuticals Inc. Recent Developments/Updates
Table 8. BASF Basic Information, Manufacturing Base and Competitors
Table 9. BASF Major Business
Table 10. BASF Non-opioid Pain Med Product and Services
Table 11. BASF Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. BASF Recent Developments/Updates
Table 13. Xinhua Pharm Basic Information, Manufacturing Base and Competitors
Table 14. Xinhua Pharm Major Business
Table 15. Xinhua Pharm Non-opioid Pain Med Product and Services
Table 16. Xinhua Pharm Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Xinhua Pharm Recent Developments/Updates
Table 18. Johnson & Johnson（McNeil Consumer Healthcare） Basic Information, Manufacturing Base and Competitors
Table 19. Johnson & Johnson（McNeil Consumer Healthcare） Major Business
Table 20. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Product and Services
Table 21. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Johnson & Johnson（McNeil Consumer Healthcare） Recent Developments/Updates
Table 23. Granules Biocause Basic Information, Manufacturing Base and Competitors
Table 24. Granules Biocause Major Business
Table 25. Granules Biocause Non-opioid Pain Med Product and Services
Table 26. Granules Biocause Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Granules Biocause Recent Developments/Updates
Table 28. Novacyl Basic Information, Manufacturing Base and Competitors
Table 29. Novacyl Major Business
Table 30. Novacyl Non-opioid Pain Med Product and Services
Table 31. Novacyl Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novacyl Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Non-opioid Pain Med Product and Services
Table 36. Pfizer Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Hisoar Basic Information, Manufacturing Base and Competitors
Table 39. Hisoar Major Business
Table 40. Hisoar Non-opioid Pain Med Product and Services
Table 41. Hisoar Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hisoar Recent Developments/Updates
Table 43. Anant Pharmaceuticals Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Anant Pharmaceuticals Pvt. Ltd. Major Business
Table 45. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product and Services
Table 46. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Anant Pharmaceuticals Pvt. Ltd. Recent Developments/Updates
Table 48. Strides Shasun Basic Information, Manufacturing Base and Competitors
Table 49. Strides Shasun Major Business
Table 50. Strides Shasun Non-opioid Pain Med Product and Services
Table 51. Strides Shasun Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Strides Shasun Recent Developments/Updates
Table 53. SI Group Basic Information, Manufacturing Base and Competitors
Table 54. SI Group Major Business
Table 55. SI Group Non-opioid Pain Med Product and Services
Table 56. SI Group Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. SI Group Recent Developments/Updates
Table 58. Elam Pharma Basic Information, Manufacturing Base and Competitors
Table 59. Elam Pharma Major Business
Table 60. Elam Pharma Non-opioid Pain Med Product and Services
Table 61. Elam Pharma Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Elam Pharma Recent Developments/Updates
Table 63. AdvaCare Pharma Basic Information, Manufacturing Base and Competitors
Table 64. AdvaCare Pharma Major Business
Table 65. AdvaCare Pharma Non-opioid Pain Med Product and Services
Table 66. AdvaCare Pharma Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. AdvaCare Pharma Recent Developments/Updates
Table 68. IOL Basic Information, Manufacturing Base and Competitors
Table 69. IOL Major Business
Table 70. IOL Non-opioid Pain Med Product and Services
Table 71. IOL Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. IOL Recent Developments/Updates
Table 73. Jingye Group Basic Information, Manufacturing Base and Competitors
Table 74. Jingye Group Major Business
Table 75. Jingye Group Non-opioid Pain Med Product and Services
Table 76. Jingye Group Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jingye Group Recent Developments/Updates
Table 78. NS Chemicals Basic Information, Manufacturing Base and Competitors
Table 79. NS Chemicals Major Business
Table 80. NS Chemicals Non-opioid Pain Med Product and Services
Table 81. NS Chemicals Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. NS Chemicals Recent Developments/Updates
Table 83. Hunan Zhongnan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. Hunan Zhongnan Pharmaceutical Major Business
Table 85. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product and Services
Table 86. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Hunan Zhongnan Pharmaceutical Recent Developments/Updates
Table 88. Nanjing Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 89. Nanjing Pharmaceutical Factory Major Business
Table 90. Nanjing Pharmaceutical Factory Non-opioid Pain Med Product and Services
Table 91. Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 93. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 94. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Major Business
Table 95. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product and Services
Table 96. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 98. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 99. Mallinckrodt Pharmaceuticals Major Business
Table 100. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product and Services
Table 101. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 103. Global Non-opioid Pain Med Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global Non-opioid Pain Med Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Non-opioid Pain Med Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in Non-opioid Pain Med, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Non-opioid Pain Med Production Site of Key Manufacturer
Table 108. Non-opioid Pain Med Market: Company Product Type Footprint
Table 109. Non-opioid Pain Med Market: Company Product Application Footprint
Table 110. Non-opioid Pain Med New Market Entrants and Barriers to Market Entry
Table 111. Non-opioid Pain Med Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Non-opioid Pain Med Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global Non-opioid Pain Med Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global Non-opioid Pain Med Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Non-opioid Pain Med Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Non-opioid Pain Med Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global Non-opioid Pain Med Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global Non-opioid Pain Med Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global Non-opioid Pain Med Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global Non-opioid Pain Med Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Non-opioid Pain Med Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Non-opioid Pain Med Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global Non-opioid Pain Med Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global Non-opioid Pain Med Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global Non-opioid Pain Med Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global Non-opioid Pain Med Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Non-opioid Pain Med Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Non-opioid Pain Med Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Non-opioid Pain Med Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America Non-opioid Pain Med Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America Non-opioid Pain Med Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America Non-opioid Pain Med Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America Non-opioid Pain Med Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America Non-opioid Pain Med Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America Non-opioid Pain Med Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America Non-opioid Pain Med Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Non-opioid Pain Med Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Non-opioid Pain Med Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe Non-opioid Pain Med Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe Non-opioid Pain Med Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe Non-opioid Pain Med Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe Non-opioid Pain Med Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe Non-opioid Pain Med Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe Non-opioid Pain Med Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Non-opioid Pain Med Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Non-opioid Pain Med Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific Non-opioid Pain Med Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific Non-opioid Pain Med Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific Non-opioid Pain Med Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific Non-opioid Pain Med Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific Non-opioid Pain Med Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific Non-opioid Pain Med Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Non-opioid Pain Med Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Non-opioid Pain Med Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America Non-opioid Pain Med Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America Non-opioid Pain Med Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America Non-opioid Pain Med Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America Non-opioid Pain Med Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America Non-opioid Pain Med Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America Non-opioid Pain Med Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Non-opioid Pain Med Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Non-opioid Pain Med Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa Non-opioid Pain Med Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa Non-opioid Pain Med Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa Non-opioid Pain Med Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa Non-opioid Pain Med Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa Non-opioid Pain Med Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa Non-opioid Pain Med Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Non-opioid Pain Med Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Non-opioid Pain Med Raw Material
Table 171. Key Manufacturers of Non-opioid Pain Med Raw Materials
Table 172. Non-opioid Pain Med Typical Distributors
Table 173. Non-opioid Pain Med Typical Customers
List of Figures
Figure 1. Non-opioid Pain Med Picture
Figure 2. Global Non-opioid Pain Med Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-opioid Pain Med Consumption Value Market Share by Type in 2022
Figure 4. Diclofenac Sodium Examples
Figure 5. Acetaminophen Examples
Figure 6. Indomethacin Examples
Figure 7. Ibuprofen Examples
Figure 8. Aspirin Examples
Figure 9. Others Examples
Figure 10. Global Non-opioid Pain Med Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Non-opioid Pain Med Consumption Value Market Share by Application in 2022
Figure 12. Mild Pain Examples
Figure 13. Moderate Pain Examples
Figure 14. Global Non-opioid Pain Med Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Non-opioid Pain Med Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Non-opioid Pain Med Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Non-opioid Pain Med Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Non-opioid Pain Med Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Non-opioid Pain Med Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Non-opioid Pain Med by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Non-opioid Pain Med Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Non-opioid Pain Med Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Non-opioid Pain Med Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Non-opioid Pain Med Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Non-opioid Pain Med Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Non-opioid Pain Med Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Non-opioid Pain Med Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Non-opioid Pain Med Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Non-opioid Pain Med Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Non-opioid Pain Med Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Non-opioid Pain Med Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Non-opioid Pain Med Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Non-opioid Pain Med Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Non-opioid Pain Med Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Non-opioid Pain Med Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Non-opioid Pain Med Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Non-opioid Pain Med Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Non-opioid Pain Med Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Non-opioid Pain Med Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Non-opioid Pain Med Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Non-opioid Pain Med Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Non-opioid Pain Med Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Non-opioid Pain Med Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Non-opioid Pain Med Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Non-opioid Pain Med Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Non-opioid Pain Med Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Non-opioid Pain Med Consumption Value Market Share by Region (2018-2029)
Figure 56. China Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Non-opioid Pain Med Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Non-opioid Pain Med Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Non-opioid Pain Med Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Non-opioid Pain Med Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Non-opioid Pain Med Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Non-opioid Pain Med Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Non-opioid Pain Med Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Non-opioid Pain Med Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Non-opioid Pain Med Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Non-opioid Pain Med Market Drivers
Figure 77. Non-opioid Pain Med Market Restraints
Figure 78. Non-opioid Pain Med Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Non-opioid Pain Med in 2022
Figure 81. Manufacturing Process Analysis of Non-opioid Pain Med
Figure 82. Non-opioid Pain Med Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source